{"id":85892,"date":"2026-04-29T06:59:43","date_gmt":"2026-04-29T14:59:43","guid":{"rendered":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2026\/04\/29\/theres-strong-public-demand-for-bigger-marijuana-reform-than-trumps-rescheduling-move-federally-funded-study-shows\/"},"modified":"2026-04-29T19:45:33","modified_gmt":"2026-04-30T03:45:33","slug":"theres-strong-public-demand-for-bigger-marijuana-reform-than-trumps-rescheduling-move-federally-funded-study-shows","status":"publish","type":"post","link":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2026\/04\/29\/theres-strong-public-demand-for-bigger-marijuana-reform-than-trumps-rescheduling-move-federally-funded-study-shows\/","title":{"rendered":"There\u2019s \u2018Strong Public Demand\u2019 For Bigger Marijuana Reform Than Trump\u2019s Rescheduling Move, Federally Funded Study Shows"},"content":{"rendered":"<\/p>\n

The Trump administration\u2019s move to reschedule marijuana<\/a> is popular, but most people support even broader cannabis reforms, according to a new federally funded study that examines public comments received during the government\u2019s official consideration of the proposal.<\/p>\n

The analysis of the 42,913 marijuana rescheduling comments submitted to the Drug Enforcement Administration (DEA) shows that 28.9 percent supported moving cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA) as proposed and that 63.5 percent wanted further rescheduling or even complete descheduling.<\/p>\n

Only 6.7 percent of commenters opposed any reform and wanted to keep marijuana in Schedule I, the most restrictive CSA category that is supposed to be reserved for substances with no accepted medical use and a high potential for abuse.<\/p>\n

The Department of Justice announced last week that marijuana products regulated by a state medical cannabis license immediately moved to Schedule III, as did any marijuana products that are approved by the Food and Drug Administration (FDA). An administrative hearing scheduled for his summer will consider broader cannabis rescheduling.<\/p>\n

\u201cPublic sentiment on Regulations.gov supports the United States Drug Enforcement Administration\u2019s proposal for cannabis rescheduling, though the majority views the proposed Schedule III classification as inadequate and supports further rescheduling or complete de-scheduling of cannabis,\u201d the new study, authored by researchers from Johns Hopkins University and the University of California San Diego and published in the journal Addiction, says.<\/p>\n

\n

\u201cThe analysis of 42,913 public comments on cannabis rescheduling reveals strong public demand for broader reforms than the proposed Schedule III reclassification.\u201d<\/p>\n<\/blockquote>\n

The research team used artificial intelligence to analyze the tens of thousands of comments, and then they manually reviewed and coded 200 of the submissions.<\/p>\n

Among those that were directly looked at by researchers, the most commonly stated reasons for supporting the move to Schedule III were therapeutic benefits and economic impacts, with those who wanted further reform citing criminal justice issues.<\/p>\n

\u201cComments also frequently highlighted social justice implications, emphasizing the need to address historical inequities from cannabis regulations, such as disproportionate incarceration rates in marginalized communities,\u201d the authors wrote.<\/p>\n

\u201cMost public comments on the proposed DEA rule-making to reschedule cannabis from Schedule I to Schedule III supported removing cannabis from Schedule I, but believed that Schedule III was insufficient and favored a lower schedule or removal from the list of controlled substances. Moreover, our analysis reveals clear public priorities: addressing therapeutic needs, promoting social equity and implementing evidence-based safety measures. These insights suggest that effective cannabis policy reform must balance public health protections with broader societal goals of accessibility and justice.\u201d<\/p>\n

Study coauthor John W. Ayers said in a press release that \u201crescheduling is a meaningful first step, but the public record shows Americans want federal policy to go even further.\u201d<\/p>\n

The fact that such a strong majority of commenters want to go further than federal officials are currently willing to \u201csuggests a disconnect between federal policy proposals and public expectations, potentially shaped by state-level legalization experiences,\u201d the study, which received federal funding from the National Institute on Drug Abuse, says.<\/p>\n

\u201cMany commenters have lived under state legalization for medical or adult use for years already,\u201d study coauthor Johannes Thrul said in the press release. \u201cTheir expectation of federal policy reflects that reality.\u201d<\/p>\n

Opponents of any change, meanwhile, frequently noted concerns about public health risks, addiction and underage use in their comments, the study found.<\/p>\n

While rescheduling doesn\u2019t broadly legalize marijuana under federal law, it does have tax benefits for state-legal cannabis businesses and removes some barriers to conducting research.<\/p>\n

\u201cPublic enthusiasm for cannabis as medicine needs to be matched by federal and state investment in rigorous cannabis research,\u201d paper coauthor Ryan Vandrey said in the press release.<\/p>\n

Vijay M. Tiyyala, another coauthor of the study<\/a>, said<\/a> that \u201cAmericans showed up with their personal stories about therapy that helped them, businesses they built, consequences of cannabis use, and more.\u201d<\/p>\n

It appears that the Trump administration recognizes broad public support for marijuana reform<\/a>.<\/p>\n

White House Press Secretary Karoline Leavitt said last week that \u201cif you do look at the public polling on this issue, it is overwhelmingly popular with the vast majority of Americans.\u201d<\/p>\n

\u201cAnd so the president was willing to take this step to do that at the behest of the American public, who largely support it, and many of his health advisors on his team who he spoke with about it,\u201d she said.<\/p>\n

During a press event in the Oval Office last week, Trump himself spoke about the medical benefits of marijuana<\/a>.<\/p>\n

\u201cA lot of people are suffering from big problems, which this seems to be the best answer,\u201d he said. \u201cThey\u2019re very happy about it. So the rescheduling is starting, and that\u2019s a big thing, rescheduling.\u201d<\/p>\n

The president noted that his administration\u2019s actions on cannabis rescheduling came after his friend Howard Kessler told him about how he used medical marijuana.<\/p>\n

\u201cHe had some medical difficulties, and he came upon this by accident, in a way,\u201d he said. \u201cHe had to go through a lot of different medications, and he said this was the one that was much better than anything else. And so he experienced that. He didn\u2019t benefit by it, other than from the standpoint that he lives a much better life now.\u201d<\/p>\n

\u201cSo hopefully you don\u2019t need it,\u201d Trump said. \u201cBut if you do need it, I hear it\u2019s the best of all the alternatives.\u201d<\/p>\n

Photo courtesy of Brian Shamblen<\/a>.<\/em><\/p>\n

The post There\u2019s \u2018Strong Public Demand\u2019 For Bigger Marijuana Reform Than Trump\u2019s Rescheduling Move, Federally Funded Study Shows<\/a> appeared first on Marijuana Moment<\/a>.<\/p>\n


\n
\nRead More: There\u2019s \u2018Strong Public Demand\u2019 For Bigger Marijuana Reform Than Trump\u2019s Rescheduling Move, Federally Funded Study Shows<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

The Trump administration\u2019s move to reschedule marijuana is popular, but most people support even broader cannabis reforms, according to a new federally funded study that examines public comments received during the government\u2019s official consideration of the proposal. The analysis of the 42,913 marijuana rescheduling comments submitted to the Drug EnforcementContinue Reading<\/a><\/span><\/p>\n","protected":false},"author":459,"featured_media":0,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[18,15462],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/85892"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/459"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=85892"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/85892\/revisions"}],"predecessor-version":[{"id":85893,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/85892\/revisions\/85893"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=85892"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=85892"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=85892"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}